Benzinga - by Avi Kapoor, Benzinga Staff Writer.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all you’re going to get from them. We have to go higher quality."
Freeport-McMoRan confirmed that Kathleen L. Quirk as its incoming president and CEO. The decision will be effective as of June 11.
AbbVie Inc. (NYSE: ABBV) is a "very good" company, the "Mad Money" host said.
AbbVie announced that its treatment for advanced Parkinson's disease is now available in Canada.
Cramer said he was an original investor in MercadoLibre, Inc. (NASDAQ: MELI), and has never once abandoned it. "Those people are incredibly smart," he added.
MercadoLibre, during November, reported better-than-expected third-quarter financial results.
Don’t forget to check out our premarket coverage here
When asked about Oxford Lane Capital Corp. (NASDAQ: OXLC), he said, "We don’t know if they’re any good at credit, and we don’t know what they own. I like the concept, and in that sense, I think I would look at Blackstone (NYSE: BX), because they really know how to do it."
Oxford Lane Capital issued net asset value update for January. Management’s unaudited estimate of the range of the NAV per share of common stock as of Jan. 31, 2024 is between $4.92 and $5.02.
Price Action:
- Shares of Oxford Lane Capital gained 1.3% to close at $5.39 on Thursday.
- AbbVie shares fell 0.1% to $174.79 on Thursday.
- MercadoLibre shares rose 1.1% to settle at $1,732.83 during Thursday’s session.
- Shares of Freeport-McMoRan fell 2.8% to close at $38.12 on Thursday.
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.